New York, USA – May 27, 2021 – Recently, CD ComputaBio, a world-renowned computational biology services provider, announced the addition of IPA analysis service to all of its businesses. All along, the team of CD ComputaBio has been committed to using their accumulated knowledge and experience in computational biology for many years to continuously expand its services so as to help scientists around the world achieve breakthroughs in the drug development.
With the continuous improvement and enrichment of computer functions, various search and analysis tools emerge in an endless stream, which has increasingly demonstrated the importance of data and the capability of information acquisition in our era. In the fields of computational biology and chemistry, complex and accurate data is also an indispensable factor in experiments and drug designs, affecting every conclusion and decision of researchers. It is this era of big data that promotes the birth and development of IPA.
IPA, the full name of which is Ingenuity Pathway Analysis, is an all-in-one and web-based software application. Unlike other search and analysis software, IPA is supported by the Ingenuity Knowledge Base with highly structured and detailed biological and chemical discoveries. Many PhD scientists manually manage the content of the knowledge base, so that researchers can obtain the latest and high-quality knowledge, novel findings and unique insights of a specific field in a timely and easy manner, thereby accelerating their experiments.
At present, targeted information about genes, proteins, chemicals, and drugs can be obtained through IPA. Scientists and drug designers rely on IPA to analyze, integrate and understand data from many aspects, such as gene expression, miRNA, and SNP microarrays, as well as metabolomics, proteomics, and RNAseq experiments. In addition, with IPA, each researcher can also establish an interactive model of experimental systems, so as to realize easy and flexible collaboration and result sharing.
“IPA is currently one of the best tools for functional analysis and knowledge discovery, which has been widely used in computational biology and chemistry,” said a spokesperson from CD ComputaBio. “Therefore, we have decided to launch the IPA analysis service to conduct biological analysis according to our customers’ specific requirements. In addition, we can also provide customers with raw data and modeling results, thus reducing time costs of them, and improving the research process.”
About CD ComputaBio
CD ComputaBio is a company specifically built to solve problems in computational biology. For many years, CD ComputaBio has been committed to assisting researchers around the world to achieve breakthroughs in drug development by providing a variety of services such as Molecular Dynamics Simulation Service and Virtual Screening Service. With professional and mature experience and technologies, CD ComputaBio has won more and more praise and trust from its customers. In the future, the company will continue to maintain its original aspirations and contribute to the development of computational biology.